Related Experiment Videos
Factors affecting survival in primary superficial bladder cancer
European Urology
|January 1, 1990
Summary
Identifying bladder cancer risk factors is crucial. Carcinoma in situ and lack of inflammation near the tumor are key indicators, alongside poor tumor differentiation, impacting survival in superficial transitional cell carcinoma.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Superficial transitional cell carcinoma (TCC) of the bladder is the most common type of bladder cancer.
- Accurate identification of prognostic factors is essential for effective patient management and treatment strategies.
Purpose of the Study:
- To identify clinical and pathological factors influencing survival in patients with primary superficial TCC of the bladder.
- To evaluate the impact of adjuvant topical instillation therapy on survival outcomes.
Main Methods:
- Retrospective analysis of 345 patients with primary superficial TCC of the bladder.
- All patients underwent transurethral resection; some received adjuvant topical instillation therapy.
- Cox regression modeling was used to identify significant risk and prognostic factors.
Main Results:
- No significant difference in 5-year survival rates between patients who received adjuvant therapy and those who did not.
- Tumor-related mortality rate was 12.5%.
- Carcinoma in situ in the tumor margin and absence of tumor-associated tissue inflammatory reaction were significant risk factors for poorer survival. Poor tumor differentiation was the most important prognostic factor.
Conclusions:
- Adjuvant topical instillation therapy did not significantly improve survival in this cohort.
- Presence of carcinoma in situ at the margin, lack of inflammatory reaction, and poor tumor differentiation are critical factors for predicting outcomes in superficial bladder TCC.